                         SEQUENCE LISTING

<110>  bluebird bio, Inc.
 
<120>  IMPROVED METHODS FOR MANUFACTURING

<130>  BLBD-028/01WO

<150>  US 61/984,558
<151>  2014-04-25

<160>  13    

<170>  PatentIn version 3.5

<210>  1
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Flexible peptide linker

<400>  1

Asp Gly Gly Gly Ser 
1               5   


<210>  2
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Flexible peptide linker

<400>  2

Thr Gly Glu Lys Pro 
1               5   


<210>  3
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Flexible peptide linker

<400>  3

Gly Gly Arg Arg 
1               


<210>  4
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Flexible peptide linker

<400>  4

Gly Gly Gly Gly Ser 
1               5   


<210>  5
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Flexible peptide linker

<400>  5

Glu Gly Lys Ser Ser Gly Ser Gly Ser Glu Ser Lys Val Asp 
1               5                   10                  


<210>  6
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Flexible peptide linker

<400>  6

Lys Glu Ser Gly Ser Val Ser Ser Glu Gln Leu Ala Gln Phe Arg Ser 
1               5                   10                  15      


Leu Asp 
        


<210>  7
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Flexible peptide linker

<400>  7

Gly Gly Arg Arg Gly Gly Gly Ser 
1               5               


<210>  8
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Flexible peptide linker

<400>  8

Leu Arg Gln Arg Asp Gly Glu Arg Pro 
1               5                   


<210>  9
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Flexible peptide linker

<400>  9

Leu Arg Gln Lys Asp Gly Gly Gly Ser Glu Arg Pro 
1               5                   10          


<210>  10
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Flexible peptide linker

<400>  10

Leu Arg Gln Lys Asp Gly Gly Gly Ser Gly Gly Gly Ser Glu Arg Pro 
1               5                   10                  15      


<210>  11
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Polypeptide cleavage sequences


<220>
<221>  MISC_FEATURE
<222>  (2)..(3)
<223>  Xaa = Any amino acid

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Xaa = Any amino acid

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  Xaa  is Gly or Ser

<400>  11

Glu Xaa Xaa Tyr Xaa Gln Xaa 
1               5           


<210>  12
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Polypeptide cleavage sequences

<400>  12

Glu Asn Leu Tyr Phe Gln Gly 
1               5           


<210>  13
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Polypeptide cleavage sequences

<400>  13

Glu Asn Leu Tyr Phe Gln Ser 
1               5           


